Medical Patent Law Weekly

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Patent Law Weekly


We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Barr Pharmaceuticals

Barr Pharmaceuticals officials provide details on the latest developments

This trend article is an immediate alert from NewsRx to identify the most recent news developments at Barr Pharmaceuticals.

Report 1: Barr Pharmaceuticals, Inc., (BRL) announced that its subsidiary, Barr Laboratories, Inc., has received tentative approval from the U.S. Food and Drug Administration (FDA) for its generic version of Roche Laboratories, Inc.'s Kytril (granisetron hydrochloride) Tablets, 1mg (base). The company anticipates receiving final approval following the expiration of Roche's patent on December 29, 2007, or on June 29, 2008 if Roche seeks and is granted...

• View Other Issues of Medical Patent Law Weekly
  
• View Other NewsRx Publications